Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAltindag, E.
dc.contributor.authorKara, B.
dc.contributor.authorBaykan, B.
dc.contributor.authorTerzibasioglu, E.
dc.contributor.authorSencer, S.
dc.contributor.authorOnat, L.
dc.contributor.authorSi, M.
dc.date.accessioned2020-12-02T18:00:15Z
dc.date.available2020-12-02T18:00:15Z
dc.date.issued2009
dc.identifier.issn1051-2284
dc.identifier.urihttps://doi.org/10.1111/j.1552-6569.2008.00325.x
dc.identifier.urihttp://hdl.handle.net/11446/3579
dc.descriptionPubMed: 19040628en_US
dc.description.abstractOur aim was to investigate the [1H] MR spectroscopy (MRS) findings of Lafora Disease (LD), which is a disabling form of progressive myoclonic epilepsy. METHODS Twelve patients diagnosed with LD and 12 control subjects underwent MRS studies with single-voxels of 8 cc obtained in the frontal lobe, pons, and cerebellum. the metabolites and NAA/Cr, NAA/Cho, Cho/Cr, mI/Cr ratios were calculated. Subgroup analysis was also done between 5 patients with EPM2B and 6 patients with EPM2A mutations. Two investigators scored neurological symptom severity. RESULTS We found a statistically significant difference of NAA/Cho ratio in LD patients compared with normal controls in cerebellum (P = 0.04). in addition, both myoclonus and ataxia scores showed significant correlation with NAA/Cho ratios in the pons (P = 0.03, P = 0.04) and in the cerebellum (P = 0.04, P = 0.01), respectively. CONCLUSION We conclude that the cerebellum is the mostly affected structure in LD and there are significant correlations of MRS findings with some clinical parameters. the differences in the group may be related to different genetic mutations besides disease duration and other clinical variables. MRS studies could provide insights about the severity of the involvement of LD. © 2009 by the American Society of Neuroimaging.en_US
dc.language.isoengen_US
dc.identifier.doi10.1111/j.1552-6569.2008.00325.xen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleMR spectroscopy findings in lafora disease: Short communicationen_US
dc.typearticleen_US
dc.relation.journalJournal of Neuroimagingen_US
dc.departmentDBÜen_US
dc.identifier.issue4en_US
dc.identifier.volume19en_US
dc.identifier.startpage359en_US
dc.identifier.endpage365en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempAltindag, E., Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Istanbul, Turkey, Department of Neurology, Istanbul Bilim University Medical Faculty, Istanbul, Turkey; Kara, B., Department of Radiology, Istanbul Bilim University Medical Faculty, Istanbul, Turkey; Baykan, B., Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Istanbul, Turkey; Terzibasioglu, E., Department of Radiology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Sencer, S., Department of Radiology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Onat, L., Department of Radiology, Istanbul Bilim University Medical Faculty, Istanbul, Turkey; Si, M., Department of Radiology, Istanbul Bilim University Medical Faculty, Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster